During the past decade, Cardiac Disease Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiac Disease Specialists" #1 sponsor was "Cardiovascular Clinical Studies" with 1 trials, followed by "Hartford Hospital" with 1 trials sponsored, "Midwest Heart Foundation" with 1 trials sponsored, "Sanofi" with 1 trials sponsored and "Vicor Technologies, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiac Disease Specialists" #1 collaborator was "GE Healthcare" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cardiac Disease Specialists" are "Coronary Artery Disease" (2 trials), "Angioplasty, Transluminal, Percutaneous Coronary" (1 trials), "Cardiac Sudden Death" (1 trials), "Cardiovascular Disease" (1 trials) and "Chronic Heart Failure" (1 trials). Many other conditions were trialed in "Cardiac Disease Specialists" in a lesser frequency.

Most popular intervention types in "Cardiac Disease Specialists" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Adenosine SPECT myocardial perfusion imaging" (1 trials), "Combined adenosine / exercise SPECT myocardial perfusion imaging" (1 trials), "Otamixaban (XRP0673)" (1 trials), "Percutaneous Coronary Intervention" (1 trials) and "Unfractionated Heparin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiac Disease Specialists" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiac Disease Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cardiac Disease Specialists, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiac Disease Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".